Evaluation of cryptogenic stroke with advanced diagnostic techniques

Stroke

Volumn 45, Issue 4, 2014, Pages 1186-1194

  Bang, Oh Young ^a   Ovbiagele, Bruce ^b   Kim, Jong S ^c  

^a Sungkyunkwan University   (South Korea)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c University of Ulsan   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

D DIMER;

ANGIOCARDIOGRAPHY; BLOOD CLOTTING DISORDER; BLOOD LEVEL; CANCER SCREENING; CEREBROVASCULAR ACCIDENT; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DIAGNOSTIC PROCEDURE; DIFFUSION WEIGHTED IMAGING; DISSEMINATED INTRAVASCULAR CLOTTING; DOPPLER ECHOGRAPHY; ECHOCARDIOGRAPHY; HOLTER MONITORING; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; INCIDENTAL FINDING; MEDICAL HISTORY; MICROEMBOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ETIOLOGY; ISCHEMIC STROKE; MAGNETIC RESONANCE IMAGING; MECHANISM;

ATRIAL FIBRILLATION; HUMANS; INTRACRANIAL EMBOLISM; MAGNETIC RESONANCE IMAGING; NEOPLASMS; STROKE; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 84897430501     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.003720     Document Type: Review

References (85)

1. Putaala J, Metso AJ, Metso TM, Konkola N, Kraemer Y, Haapaniemi E, et al. Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: The Helsinki young stroke registry. Stroke. 2009;40:1195-1203.
2. Grau AJ, Weimar C, Buggle F, Heinrich A, Goertler M, Neumaier S, et al. Risk factors, outcome, and treatment in subtypes of ischemic stroke: The German stroke data bank. Stroke. 2001;32:2559-2566.
3. Bang OY, Lee PH, Joo SY, Lee JS, Joo IS, Huh K. Frequency and mechanisms of stroke recurrence after cryptogenic stroke. Ann Neurol. 2003;54:227-234.
4. Bal S, Patel SK, Almekhlafi M, Modi J, Demchuk AM, Coutts SB. High rate of magnetic resonance imaging stroke recurrence in cryptogenic transient ischemic attack and minor stroke patients. Stroke. 2012;43:3387-3388.
5. Kullo IJ, Edwards WD, Schwartz RS. Vulnerable plaque: Pathobiology and clinical implications. Ann Intern Med. 1998;129:1050-1060.
6. Stone GW, Maehara A, Lansky AJ, de Bruyne B, Cristea E, Mintz GS, et al PROSPECT Investigators. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011;364:226-235.
7. Ryoo S, Park JH, Kim SJ, Kim GM, Chung CS, Lee KH, et al. Branch occlusive disease: Clinical and magnetic resonance angiography findings. Neurology. 2012;78:888-896.
8. Bang OY, Joo SY, Lee PH, Joo US, Lee JH, Joo IS, et al. The course of patients with lacunar infarcts and a parent arterial lesion: Similarities to large artery vs small artery disease. Arch Neurol. 2004;61:514-519.
9. Rizos T, Wagner A, Jenetzky E, Ringleb PA, Becker R, Hacke W, et al. Paroxysmal atrial fibrillation is more prevalent than persistent atrial fibrillation in acute stroke and transient ischemic attack patients. Cerebrovasc Dis. 2011;32:276-282.
10. Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, et al ASSERT Investigators Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012;366:120-129.
11. Lip GY, Frison L, Grind M; SPORTIF Investigators Stroke event rates in anticoagulated patients with paroxysmal atrial fibrillation. J Intern Med. 2008;264:50-61.
12. Ferro JM, Massaro AR, Mas JL. Aetiological diagnosis of ischaemic stroke in young adults. Lancet Neurol. 2010;9:1085-1096.
13. Alsheikh-Ali AA, Thaler DE, Kent DM. Patent foramen ovale in cryptogenic stroke: Incidental or pathogenic? Stroke. 2009;40:2349-2355.
14. Kent DM, Thaler DE. Is patent foramen ovale a modifiable risk factor for stroke recurrence? Stroke. 2010;41(suppl 10):S26-S30.
15. Kim SG, Hong JM, Kim HY, Lee J, Chung PW, Park KY, et al. Ischemic stroke in cancer patients with and without conventional mechanisms: A multicenter study in Korea. Stroke. 2010;41:798-801.
16. Seok JM, Kim SG, Kim JW, Chung CS, Kim GM, Lee KH, et al. Coagulopathy and embolic signal in cancer patients with ischemic stroke. Ann Neurol. 2010;68:213-219.
17. Bick RL. Cancer-Associated thrombosis. N Engl J Med. 2003;349: 109-111.
18. Rickles FR, Patierno S, Fernandez PM. Tissue factor, thrombin, and cancer. Chest. 2003;124(suppl 3):58S-68S.
19. Li SH, Chen WH, Tang Y, Rau KM, Chen YY, Huang TL, et al. Incidence of ischemic stroke post-chemotherapy: A retrospective review of 10,963 patients. Clin Neurol Neurosurg. 2006;108:150-156.
20. Briley-Saebo KC, Mulder WJ, Mani V, Hyafil F, Amirbekian V, Aguinaldo JG, et al. Magnetic resonance imaging of vulnerable atherosclerotic plaques: Current imaging strategies and molecular imaging probes. J Magn Reson Imaging. 2007;26:460-479.
21. Cai JM, Hatsukami TS, Ferguson MS, Small R, Polissar NL, Yuan C. Classification of human carotid atherosclerotic lesions with in vivo multicontrast magnetic resonance imaging. Circulation. 2002;106: 1368-1373.
22. Saam T, Ferguson MS, Yarnykh VL, Takaya N, Xu D, Polissar NL, et al. Quantitative evaluation of carotid plaque composition by in vivo MRI. Arterioscler Thromb Vasc Biol. 2005;25:234-239.
23. Parmar JP, Rogers WJ, Mugler JP III, Baskurt E, Altes TA, Nandalur KR, et al. Magnetic resonance imaging of carotid atherosclerotic plaque in clinically suspected acute transient ischemic attack and acute ischemic stroke. Circulation. 2010;122:2031-2038.
24. Madani A, Beletsky V, Tamayo A, Munoz C, Spence JD. High-risk asymptomatic carotid stenosis: Ulceration on 3D ultrasound vs TCD microemboli. Neurology. 2011;77:744-750.
25. Partovi S, Loebe M, Aschwanden M, Baldi T, Jäger KA, Feinstein SB, et al. Contrast-enhanced ultrasound for assessing carotid atherosclerotic plaque lesions. AJR Am J Roentgenol. 2012;198:W13-W19.
26. Bodle JD, Feldmann E, Swartz RH, Rumboldt Z, Brown T, Turan TN. High-resolution magnetic resonance imaging: An emerging tool for evaluating intracranial arterial disease. Stroke. 2013;44:287-292.
27. Schoenhagen P, Ziada KM, Kapadia SR, Crowe TD, Nissen SE, Tuzcu EM. Extent and direction of arterial remodeling in stable versus unstable coronary syndromes: An intravascular ultrasound study. Circulation. 2000;101:598-603.
28. Shi MC, Wang SC, Zhou HW, Xing YQ, Cheng YH, Feng JC, et al. Compensatory remodeling in symptomatic middle cerebral artery atherosclerotic stenosis: A high-resolution MRI and microemboli monitoring study. Neurol Res. 2012;34:153-158.
29. Xu WH, Li ML, Gao S, Ni J, Zhou LX, Yao M, et al. Plaque distribution of stenotic middle cerebral artery and its clinical relevance. Stroke. 2011;42:2957-2959.
30. Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, et al American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease; Council on Clinical Cardiology. Guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:870-947.
31. Douen AG, Pageau N, Medic S. Serial electrocardiographic assessments significantly improve detection of atrial fibrillation 2.6-fold in patients with acute stroke. Stroke. 2008;39:480-482.
32. Khan M, Miller DJ. Detection of paroxysmal atrial fibrillation in stroke/ tia patients. Stroke Res Treat. 2013;2013:840265.
33. Jabaudon D, Sztajzel J, Sievert K, Landis T, Sztajzel R. Usefulness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack. Stroke. 2004;35:1647-1651.
34. Rizos T, Güntner J, Jenetzky E, Marquardt L, Reichardt C, Becker R, et al. Continuous stroke unit electrocardiographic monitoring versus 24-hour Holter electrocardiography for detection of paroxysmal atrial fibrillation after stroke. Stroke. 2012;43:2689-2694.
35. Kallmünzer B, Breuer L, Hering C, Raaz-Schrauder D, Kollmar R, Huttner HB, et al. A structured reading algorithm improves telemetric detection of atrial fibrillation after acute ischemic stroke. Stroke. 2012;43:994-999.
36. Stahrenberg R, Weber-Krüger M, Seegers J, Edelmann F, Lahno R, Haase B, et al. Enhanced detection of paroxysmal atrial fibrillation by early and prolonged continuous holter monitoring in patients with cerebral ischemia presenting in sinus rhythm. Stroke. 2010;41:2884-2888.
37. Barthélémy JC, Féasson-Gérard S, Garnier P, Gaspoz JM, Da Costa A, Michel D, et al. Automatic cardiac event recorders reveal paroxysmal atrial fibrillation after unexplained strokes or transient ischemic attacks. Ann Noninvasive Electrocardiol. 2003;8:194-199.
38. Gaillard N, Deltour S, Vilotijevic B, Hornych A, Crozier S, Leger A, et al. Detection of paroxysmal atrial fibrillation with transtelephonic EKG in TIA or stroke patients. Neurology. 2010;74:1666-1670.
39. Miller DJ, Khan MA, Schultz LR, Simpson JR, Katramados AM, Russman AN, et al. Outpatient cardiac telemetry detects a high rate of atrial fibrillation in cryptogenic stroke. J Neurol Sci. 2013;324:57-61.
40. Tayal AH, Tian M, Kelly KM, Jones SC, Wright DG, Singh D, et al. Atrial fibrillation detected by mobile cardiac outpatient telemetry in cryptogenic TIA or stroke. Neurology. 2008;71:1696-1701.
41. Bhatt A, Majid A, Razak A, Kassab M, Hussain S, Safdar A. Predictors of occult paroxysmal atrial fibrillation in cryptogenic strokes detected by long-Term noninvasive cardiac monitoring. Stroke Res Treat. 2011;2011:172074.
42. Dion F, Saudeau D, Bonnaud I, Friocourt P, Bonneau A, Poret P, et al. Unexpected low prevalence of atrial fibrillation in cryptogenic ischemic stroke: A prospective study. J Interv Card Electrophysiol. 2010;28:101-107.
43. Flint AC, Banki NM, Ren X, Rao VA, Go AS. Detection of paroxysmal atrial fibrillation by 30-day event monitoring in cryptogenic ischemic stroke: The Stroke and Monitoring for PAF in Real Time (SMART) Registry. Stroke. 2012;43:2788-2790.
44. Ritter MA, Kochhäuser S, Duning T, Reinke F, Pott C, Dechering DG, et al. Occult atrial fibrillation in cryptogenic stroke: Detection by 7-day electrocardiogram versus implantable cardiac monitors. Stroke. 2013;44:1449-1452.
45. Cotter PE, Martin PJ, Ring L, Warburton EA, Belham M, Pugh PJ. Incidence of atrial fibrillation detected by implantable loop recorders in unexplained stroke. Neurology. 2013;80:1546-1550.
46. Ziegler PD, Glotzer TV, Daoud EG, Wyse DG, Singer DE, Ezekowitz MD, et al. Incidence of newly detected atrial arrhythmias via implantable devices in patients with a history of thromboembolic events. Stroke. 2010;41:256-260.
47. de Bruijn SF, Agema WR, Lammers GJ, van der Wall EE, Wolterbeek R, Holman ER, et al. Transesophageal echocardiography is superior to transthoracic echocardiography in management of patients of any age with transient ischemic attack or stroke. Stroke. 2006;37:2531-2534.
48. Hur J, Kim YJ, Lee HJ, Nam JE, Ha JW, Heo JH, et al. Dual-enhanced cardiac CT for detection of left atrial appendage thrombus in patients with stroke: A prospective comparison study with transesophageal echocardiography. Stroke. 2011;42:2471-2477.
49. Taina M, Vanninen R, Hedman M, Jäkälä P, Kärkkäinen S, Tapiola T, et al. Left atrial appendage volume increased in more than half of patients with cryptogenic stroke. PLoS One. 2013;8:e79519.
50. Di Biase L, Santangeli P, Anselmino M, Mohanty P, Salvetti I, Gili S, et al. Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study. J Am Coll Cardiol. 2012;60:531-538.
51. Kapral MK, Silver FL. Preventive health care, 1999 update: 2. Echocardiography for the detection of a cardiac source of embolus in patients with stroke. Canadian Task Force on Preventive Health Care. CMAJ. 1999;161:989-996.
52. Cho HJ, Choi HY, Kim YD, Nam HS, Han SW, Ha JW, et al. Transoesophageal echocardiography in patients with acute stroke with sinus rhythm and no cardiac disease history. J Neurol Neurosurg Psychiatry. 2010;81:412-415.
53. Hur J, Kim YJ, Lee HJ, Ha JW, Heo JH, Choi EY, et al. Cardiac computed tomographic angiography for detection of cardiac sources of embolism in stroke patients. Stroke. 2009;40:2073-2078.
54. Kim SJ, Choe YH, Park SJ, Kim GM, Chung CS, Lee KH, et al. Routine cardiac evaluation in patients with ischaemic stroke and absence of known atrial fibrillation or coronary heart disease: Transthoracic echocardiography vs. multidetector cardiac computed tomography. Eur J Neurol. 2012;19:317-323.
55. Kim YJ, Hur J, Shim CY, Lee HJ, Ha JW, Choe KO, et al. Patent foramen ovale: Diagnosis with multidetector CT-comparison with transesophageal echocardiography. Radiology. 2009;250:61-67.
56. Hussain SI, Gilkeson RC, Suarez JI, Tarr R, Schluchter M, Landis DM, et al. Comparing multislice electrocardiogram-gated spiral computerized tomography and transesophageal echocardiography in evaluating aortic atheroma in patients with acute ischemic stroke. J Stroke Cerebrovasc Dis. 2008;17:134-140.
57. Sipola P, Hedman M, Onatsu J, Turpeinen A, Halinen M, Jäkälä P, et al. Computed tomography and echocardiography together reveal more high-risk findings than echocardiography alone in the diagnostics of stroke etiology. Cerebrovasc Dis. 2013;35:521-530.
58. Karttunen V, Ventilä M, Ikäheimo M, Niemelä M, Hillbom M. Ear oximetry: A noninvasive method for detection of patent foramen ovale: A study comparing dye dilution method and oximetry with contrast transesophageal echocardiography. Stroke. 2001;32:448-453.
59. Bushnell CD, Goldstein LB. Diagnostic testing for coagulopathies in patients with ischemic stroke. Stroke. 2000;31:3067-3078.
60. Kim SJ, Park JH, Lee MJ, Park YG, Ahn MJ, Bang OY. Clues to occult cancer in patients with ischemic stroke. PLoS One. 2012;7:e44959.
61. Singhal AB, Topcuoglu MA, Buonanno FS. Acute ischemic stroke patterns in infective and nonbacterial thrombotic endocarditis: A diffusion-weighted magnetic resonance imaging study. Stroke. 2002;33:1267-1273.
62. Wessels T, Wessels C, Ellsiepen A, Reuter I, Trittmacher S, Stolz E, et al. Contribution of diffusion-weighted imaging in determination of stroke etiology. AJNR Am J Neuroradiol. 2006;27:35-39.
63. Mustanoja S, Putaala J, Haapaniemi E, Strbian D, Kaste M, Tatlisumak T. Multiple brain infarcts in young adults: Clues for etiologic diagnosis and prognostic impact. Eur J Neurol. 2013;20:216-222.
64. Lee LJ, Kidwell CS, Alger J, Starkman S, Saver JL. Impact on stroke subtype diagnosis of early diffusion-weighted magnetic resonance imaging and magnetic resonance angiography. Stroke. 2000;31: 1081-1089.
65. Fujimoto S, Toyoda K, Jinnouchi J, Yasaka M, Kitazono T, Okada Y. Differences in diffusion-weighted image and transesophageal echocardiographical findings in cardiogenic, paradoxical and aortogenic brain embolism. Cerebrovasc Dis. 2011;32:148-154.
66. Bang OY, Lee PH, Heo KG, Joo US, Yoon SR, Kim SY. Specific DWI lesion patterns predict prognosis after acute ischaemic stroke within the MCA territory. J Neurol Neurosurg Psychiatry. 2005;76:1222-1228.
67. Shin DH, Lee PH, Bang OY. Mechanisms of recurrence in subtypes of ischemic stroke: A hospital-based follow-up study. Arch Neurol. 2005;62: 1232-1237.
68. Yoon Y, Lee DH, Kang DW, Kwon SU, Suh DC, Bang OY, et al. Stroke recurrence patterns are predicted by the subtypes and mechanisms of the past, non-cardiogenic stroke. Eur J Neurol. 2013;20:928-934.
69. Cho AH, Kwon SU, Kim TW, Lee SJ, Shon YM, Kim BS, et al. High prevalence of unrecognized cerebral infarcts in first-ever stroke patients with cardioembolic sources. Eur J Neurol. 2009;16:838-842.
70. Nah HW, Kang DW, Kwon SU, Kim JS. Diversity of single small subcortical infarctions according to infarct location and parent artery disease: Analysis of indicators for small vessel disease and atherosclerosis. Stroke. 2010;41:2822-2827.
71. Rodríguez-Yáñez M, Arias-Rivas S, Santamaría-Cadavid M, Sobrino T, Castillo J, Blanco M. High pro-BNP levels predict the occurrence of atrial fibrillation after cryptogenic stroke. Neurology. 2013;81: 444-447.
72. Patton KK, Heckbert SR, Alonso A, Bahrami H, Lima JA, Burke G, et al. N-Terminal pro-B-Type natriuretic peptide as a predictor of incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis: The effects of age, sex and ethnicity. Heart. 2013;99:1832-1836.
73. Montaner J, Perea-Gainza M, Delgado P, Ribó M, Chacón P, Rosell A, et al. Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers. Stroke. 2008;39:2280-2287.
74. Castellanos M, Serena J, Segura T, Pérez-Ayuso MJ, Silva Y, Dávalos A. Atherosclerotic aortic arch plaques in cryptogenic stroke: A microembolic signal monitoring study. Eur Neurol. 2001;45: 145-150.
75. Kim SJ, Ryoo S, Hwang J, Noh HJ, Park JH, Choe YH, et al. Characterization of the infarct pattern caused by vulnerable aortic arch atheroma: DWI and multidetector row CT study. Cerebrovasc Dis. 2012;33:549-557.
76. Masuda J, Yutani C, Ogata J, Kuriyama Y, Yamaguchi T. Atheromatous embolism in the brain: A clinicopathologic analysis of 15 autopsy cases. Neurology. 1994;44:1231-1237.
77. Ueno Y, Kimura K, Iguchi Y, Shibazaki K, Inoue T, Hattori N, et al. Mobile aortic plaques are a cause of multiple brain infarcts seen on diffusion-weighted imaging. Stroke. 2007;38:2470-2476.
78. Jauss M, Wessels T, Trittmacher S, Allendörfer J, Kaps M. Embolic lesion pattern in stroke patients with patent foramen ovale compared with patients lacking an embolic source. Stroke. 2006;37: 2159-2161.
79. Kim JW, Kim SJ, Yoon CW, Park CH, Kang KW, Kim SK, et al. Association between the amount of right-To-left shunt and infarct patterns in patients with cryptogenic embolic stroke: A transcranial Doppler study. Int J Stroke. 2013;8:657-662.
80. Kent DM, Ruthazer R, Weimar C, Mas JL, Serena J, Homma S, et al. An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology. 2013;81:619-625.
81. Rigatelli G, Aggio S, Cardaioli P, Braggion G, Giordan M, Dell'avvocata F, et al. Left atrial dysfunction in patients with patent foramen ovale and atrial septal aneurysm: An alternative concurrent mechanism for arterial embolism? JACC Cardiovasc Interv. 2009;2:655-662.
82. Cotter PE, Martin PJ, Pugh PJ, Warburton EA, Cheriyan J, Belham M. Increased incidence of interatrial block in younger adults with cryptogenic stroke and patent foramen ovale. Cerebrovasc Dis Extra. 2011;1:36-43.
83. Traylor M, Farrall M, Holliday EG, Sudlow C, Hopewell JC, Cheng YC, et al; Australian Stroke Genetics Collaborative, Wellcome Trust Case Control Consortium 2 (WTCCC2); International Stroke Genetics Consortium. Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): A meta-Analysis of genome-wide association studies. Lancet Neurol. 2012;11:951-962.
84. Jickling GC, Xu H, Stamova B, Ander BP, Zhan X, Tian Y, et al. Signatures of cardioembolic and large-vessel ischemic stroke. Ann Neurol. 2010;68:681-692.
85. Jickling GC, Stamova B, Ander BP, Zhan X, Liu D, Sison SM, et al. Prediction of cardioembolic, arterial, and lacunar causes of cryptogenic stroke by gene expression and infarct location. Stroke. 2012;43:2036-2041.